Skip to main content
SpringerLink
Log in

The efficacy and safety of insertable cardiac monitor on atrial fibrillation detection in patients with ischemic stroke: a systematic review and meta-analysis

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Atrial fibrillation (AF) leads to a high risk of recurrent stroke, and the insertable cardiac monitor (ICM), as a new kind of electrocardiographic monitoring device, has been proven to enhance the recognition rate of AF. The aim of this systematic review was to evaluate the efficacy and safety of the ICM use in AF detection of patients with stroke. We pooled 1233 patients from three randomized controlled trials (RCTs). The detection rate of AF was superior in the ICM group to that in the control group at 6 months (risk ratio [RR], 4.63; P < 0.0001; 95% confidence interval [CI], 2.17–9.90) and 12 months (RR, 5.04; P < 0.00001; 95% CI, 2.93 to 8.68). Patients in the ICM group had a higher rate of oral anticoagulant usage (RR, 2.76; P < 0.00001; 95% CI, 1.89–4.02). However, there was no difference in the time to first detection of AF within 12 months (mean difference, − 8.28; P = 0.82; 95% CI, − 77.84–61.28) or the rate of recurrent ischemic stroke or transient ischemic attack (RR, 0.88; P = 0.51; 95% CI, 0.60–1.28) between the ICM and control groups. In addition, the ICM group experienced more adverse events than the control group within 12 months (RR, 4.42; P = 0.002; 95% CI, 1.69–11.55). To conclude, the sensitivity of ICM is superior to that of conventional external cardiac monitoring. Reducing adverse reactions will be a new development direction of ICM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article and its supplementary information files.

Code availability

Not applicable.

References

  1. Feigin VL et al (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol 20(10):795–820. https://doi.org/10.1016/s1474-4422(21)00252-0

    Article  CAS  Google Scholar 

  2. Freedman B, Potpara TS, Lip GY (2016) Stroke prevention in atrial fibrillation. Lancet 388(10046):806–817. https://doi.org/10.1016/s0140-6736(16)31257-0

    Article  PubMed  Google Scholar 

  3. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN et al (2020) Heart disease and stroke statistics-2020 update: a report from the american heart association. Circulation 141(9):e139–e596. https://doi.org/10.1161/cir.0000000000000757

    Article  PubMed  Google Scholar 

  4. Kimura K, Minematsu K, Yamaguchi T (2005) Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 76(5):679–683. https://doi.org/10.1136/jnnp.2004.048827

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 342(8882):1255–1262

  6. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–2747. https://doi.org/10.1093/eurheartj/ehs253

    Article  PubMed  Google Scholar 

  7. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ (2013) Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 80(17):1546–1550. https://doi.org/10.1212/WNL.0b013e31828f1828

    Article  PubMed  PubMed Central  Google Scholar 

  8. Etgen T, Hochreiter M, Mundel M, Freudenberger T (2013) Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke: an audit report. Stroke 44(7):2007–2009. https://doi.org/10.1161/STROKEAHA.113.001340

    Article  PubMed  Google Scholar 

  9. Douen AG, Pageau N, Medic S (2008) Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke 39(2):480–482. https://doi.org/10.1161/STROKEAHA.107.492595

    Article  PubMed  Google Scholar 

  10. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R (2004) Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 35(7):1647–1651. https://doi.org/10.1161/01.STR.0000131269.69502.d9

    Article  PubMed  Google Scholar 

  11. Higgins P, MacFarlane PW, Dawson J, McInnes GT, Langhorne P, Lees KR (2013) Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke 44(9):2525–2531. https://doi.org/10.1161/strokeaha.113.001927

    Article  PubMed  Google Scholar 

  12. Manina G, Agnelli G, Becattini C, Zingarini G, Paciaroni M (2014) 96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack. Intern Emerg Med 9(1):65–67. https://doi.org/10.1007/s11739-012-0755-3

    Article  PubMed  Google Scholar 

  13. Burkowitz J, Merzenich C, Grassme K, Bruggenjurgen B (2016) Insertable cardiac monitors in the diagnosis of syncope and the detection of atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol 23(12):1261–1272. https://doi.org/10.1177/2047487316632628

    Article  PubMed  Google Scholar 

  14. Kanters TA, Wolff C, Boyson D, Kouakam C, Dinh T, Hakkaart L, Rutten-Van Mölken MP (2016) Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room. Europace 18(6):919–924. https://doi.org/10.1093/europace/euv217

    Article  PubMed  Google Scholar 

  15. De Angelis MV, Di Stefano V, Franciotti R, Furia N, Di Girolamo E, Onofrj M, Faustino M (2020) Cryptogenic stroke and atrial fibrillation in a real-world population: the role of insertable cardiac monitors. Sci Rep 10(1):3230. https://doi.org/10.1038/s41598-020-60180-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Drak-Hernández Y, Toquero-Ramos J, Fernández JM, Pérez-Pereira E, Castro-Urda V, Fernández-Lozano I (2013) Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (English ed) 66(12):943–948. https://doi.org/10.1016/j.rec.2013.06.009

    Article  Google Scholar 

  17. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res ed) 339:b2700. https://doi.org/10.1136/bmj.b2700

    Article  Google Scholar 

  18. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F et al (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370(26):2478–2486. https://doi.org/10.1056/NEJMoa1313600

    Article  CAS  PubMed  Google Scholar 

  19. Bernstein RA, Kamel H, Granger CB, Piccini JP, Sethi PP, Katz JM, Vives CA, Ziegler PD, Franco NC, Schwamm LH et al (2021) Effect of long-term continuous cardiac monitoring vs usual care on detection of atrial fibrillation in patients with stroke attributed to large- or small-vessel disease: the STROKE-AF randomized clinical trial. JAMA 325(21):2169–2177. https://doi.org/10.1001/jama.2021.6470

    Article  PubMed  PubMed Central  Google Scholar 

  20. Buck BH, Hill MD, Quinn FR, Butcher KS, Menon BK, Gulamhusein S, Siddiqui M, Coutts SB, Jeerakathil T, Smith EE et al (2021) Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: the per diem randomized clinical trial. JAMA 325(21):2160–2168. https://doi.org/10.1001/jama.2021.6128

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kulach A, Dewerenda M, Majewski M, Lasek-Bal A, Gasior Z (2021) Supraventricular Runs in 7-day holter monitoring are related to increased incidence of atrial fibrillation in a 3-year follow-up of cryptogenic stroke patients free from arrhythmia in a 24 h-holter. J Cardiovasc Dev Dis. https://doi.org/10.3390/jcdd8070081

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kishore A, Vail A, Majid A, Dawson J, Lees KR, Tyrrell PJ, Smith CJ (2014) Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke 45(2):520–526. https://doi.org/10.1161/strokeaha.113.003433

    Article  CAS  PubMed  Google Scholar 

  23. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988. https://doi.org/10.1161/01.str.22.8.983

    Article  CAS  PubMed  Google Scholar 

  24. Li L, Yiin GS, Geraghty OC, Schulz UG, Kuker W, Mehta Z, Rothwell PM (2015) Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 14(9):903–913. https://doi.org/10.1016/s1474-4422(15)00132-5

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, Sacco RL, Connolly SJ (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13(4):429–438. https://doi.org/10.1016/s1474-4422(13)70310-7

    Article  PubMed  Google Scholar 

  26. Katz JM, Eng MS, Carrazco C, Patel AV, Jadonath R, Gribko M, Arora R, Libman RB (2018) Occult paroxysmal atrial fibrillation in non-cryptogenic ischemic stroke. J Neurol 265(10):2237–2242. https://doi.org/10.1007/s00415-018-8982-9

    Article  PubMed  Google Scholar 

  27. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Georg Haeusler K, Oldgren J, Reinecke H, Roldan-Schilling V et al (2018) The 2018 european heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace 20(8):1231–1242. https://doi.org/10.1093/europace/euy054

    Article  PubMed  Google Scholar 

  28. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120–129. https://doi.org/10.1056/NEJMoa1105575

    Article  CAS  PubMed  Google Scholar 

  29. Seet RC, Friedman PA, Rabinstein AA (2011) Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation 124(4):477–486. https://doi.org/10.1161/circulationaha.111.029801

    Article  PubMed  Google Scholar 

  30. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 74(1):104–132. https://doi.org/10.1016/j.jacc.2019.01.011

    Article  PubMed  Google Scholar 

  31. Healey JS, Alings M, Ha A, Leong-Sit P, Birnie DH, de Graaf JJ, Freericks M, Verma A, Wang J, Leong D et al (2017) Subclinical atrial fibrillation in older patients. Circulation 136(14):1276–1283. https://doi.org/10.1161/CIRCULATIONAHA.117.028845

    Article  PubMed  Google Scholar 

  32. Diederichsen SZ, Haugan KJ, Højberg S, Holst AG, Køber L, Pedersen KB, Graff C, Krieger D, Brandes A, Svendsen JH (2017) Complications after implantation of a new-generation insertable cardiac monitor: results from the LOOP study. Int J Cardiol 241:229–234. https://doi.org/10.1016/j.ijcard.2017.03.144

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Suzhou Health Talents Training Project (GSWS2019002).

Author information

Author notes

  1. Xin Tan, Zilan Wang and Xin Wu contribute equally to this work.

Authors and Affiliations

  1. Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China

    Xin Tan, Zilan Wang, Xin Wu, Jie Zhang, Zhaoming Song, Youjia Qiu, Zhouqing Chen, Zhong Wang & Gang Chen

  2. Department of Neurology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, 215002, Jiangsu Province, China

    Xin Tan

  3. Department of Neurosurgery, Suzhou Ninth People’s Hospital, Suzhou, 215200, Jiangsu Province, China

    Xin Wu

Authors
  1. Xin Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zilan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xin Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhaoming Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Youjia Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhouqing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XT and ZLW was the principal investigator. XT and XW designed the study and developed the analysis plan. XW, XT and JZ analyzed the data and performed meta-analysis. TX and ZLW contributed in writing of the article. ZMS and YJQ revised the manuscript and polish the language. ZQC, ZW and GC supervised the project. All authors read and approved the final submitted paper.

Corresponding authors

Correspondence to Zhouqing Chen or Zhong Wang.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interests.

Ethics approval

We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 348 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, X., Wang, Z., Wu, X. et al. The efficacy and safety of insertable cardiac monitor on atrial fibrillation detection in patients with ischemic stroke: a systematic review and meta-analysis. J Neurol 269, 2338–2345 (2022). https://doi.org/10.1007/s00415-021-10903-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-021-10903-0

Keywords

Search

Navigation